Skip to main content
Log in

Direct oral anticoagulant successfully used to treat an adult nephrotic patient complicated with portal vein thrombosis

  • Case Report
  • Published:
CEN Case Reports Aims and scope Submit manuscript

Abstract

Thromboembolism is a major complication of nephrotic syndrome, with the renal vein being the most frequent site. However, the incidence of portal vein thrombosis (PVT) in patients with nephrotic syndrome is rare. We report a case of a relapsed steroid-dependent minimal change disease with incidental PVT. A 38-year-old man presented with anasarca. Elevated liver enzymes were discovered during routine blood testing within days after commencing treatment. Although drug-induced liver injuries are frequently observed with mild aminotransferase abnormality during therapy with steroid or immune-suppressive agents, imaging revealed a massive thrombus of the portal vein, which was treated by anticoagulant therapy with edoxaban. Treatment with anticoagulant therapy could normalize liver function. Two months after the initiation of treatment with edoxaban, the follow-up CT scan and ultrasound showed the disappearance of PVT. Our case suggests that much attention should be paid to PVT as a cause of liver enzyme elevation when treating patients with nephrotic syndrome.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Rosendaal FR. Venous thrombosis: a multicausal disease. Lancet. 1999;353:1167–73.

    Article  CAS  PubMed  Google Scholar 

  2. Al-Azzawi HF, Obi OC, Safi J, Song M. Nephrotic syndrome-induced thromboembolism in adults. Int J Crit Illn Inj Sci. 2016;6:85–8.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Sexton DJ, de Freitas DG, Little MA, McHugh T, Magee C, Conlon PJ, O’Seaghdha CM. Direct-acting oral anticoagulants as prophylaxis against thromboembolism in the nephrotic syndrome. Kidney Int Rep. 2018;3:784–93.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Gigante A, Di Mario F, Pierucci A, Amoroso A, Pignataro FS, Napoleone L, Basili S, Raparelli V. Kidney disease and venous thromboembolism: does being woman make the difference? Eur J Intern Med. 2017;39:18–23.

    Article  CAS  PubMed  Google Scholar 

  5. Barbano B, Gigante A, Amoroso A, Cianci R. Thrombosis in nephrotic syndrome. Semin Thromb Hemost. 2013;39:469–76.

    Article  CAS  PubMed  Google Scholar 

  6. Etoh Y, Ohsawa I, Fujita T, Fuke Y, Endo M, Ohi H, Kumasaka K. Nephrotic syndrome with portal, splenic and renal vein thrombosis. A case report. Nephron. 2002;92:680–4.

    Article  PubMed  Google Scholar 

  7. Mahmoodi BK, ten Kate MK, Waanders F, Veeger NJ, Brouwer JL, Vogt L, Navis G, van der Meer J. High absolute risks and predictors of venous and arterial thromboembolic events in patients with nephrotic syndrome: results from a large retrospective cohort study. Circulation. 2008;117:224–30.

    Article  PubMed  Google Scholar 

  8. Primignani M. Portal vein thrombosis, revisited. Dig Liver Dis. 2010;42:163–70.

    Article  PubMed  Google Scholar 

  9. Amitrano L, Guardascione MA, Brancaccio V, Margaglione M, Manguso F, Iannaccone L, Grandone E, Balzano A. Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis. J Hepatol. 2004;40:736–41.

    Article  PubMed  Google Scholar 

  10. Weitz JI. Low-molecular-weight heparins. N Engl J Med. 1997;337:688–98.

    Article  CAS  PubMed  Google Scholar 

  11. Tripodi A, Anstee QM, Sogaard KK, Primignani M, Valla DC. Hypercoagulability in cirrhosis: causes and consequences. J Thromb Haemost. 2011;9:1713–23.

    Article  CAS  PubMed  Google Scholar 

  12. DeLeve LD, Valla DC, Garcia-Tsao G. Vascular disorders of the liver. Hepatology. 2009;49:1729–64.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Kearon C, Akl EA, Comerota AJ, Prandoni P, Bounameaux H, Goldhaber SZ, Nelson ME, Wells PS, Gould MK, Dentali F, Crowther M, Kahn SR. Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141:e419S–494S.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Priyanka P, Kupec JT, Krafft M, Shah NA, Reynolds GJ. Newer oral anticoagulants in the treatment of acute portal vein thrombosis in patients with and without cirrhosis. Int J Hepatol. 2018; 2018:8432781.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hideharu Abe.

Ethics declarations

Conflict of interest

All authors declare that they have no conflict of interest.

Human and animal rights

This article contains no studies involving humans or animals.

Informed consent

Informed consent was obtained from the patient whose case is reported in this study.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee at which the studies were conducted (IRB Approval Number 680-2) and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Obata, F., Abe, H., Murakami, T. et al. Direct oral anticoagulant successfully used to treat an adult nephrotic patient complicated with portal vein thrombosis. CEN Case Rep 8, 134–138 (2019). https://doi.org/10.1007/s13730-019-00381-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13730-019-00381-9

Keywords

Navigation